Tight Margins, Federal Regulations Constrain Infectious Disease MDx for Animal Health | GenomeWeb

In the first part of this two-part story, GenomeWeb spoke with commercial developers, end users, and federal regulators to understand whether the animal health market is a parallel path or a parallel universe in MDx. Part two of the story can be read here.

NEW YORK (GenomeWeb) – Detecting pathogens' nucleic acids by using molecular techniques is an active, growing market segment in healthcare, and this is true for both humans and non-human animals.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.